logo
Trump Budget Cuts Funding for Chronic Disease Prevention

Trump Budget Cuts Funding for Chronic Disease Prevention

New York Times02-05-2025

Robert F. Kennedy Jr., the nation's health secretary, has said that tackling a chronic disease 'epidemic' would be a cornerstone of his Make America Healthy Again agenda, often invoking alarming statistics as an urgent reason for reforming public health in this country.
On Friday, President Trump released a proposed budget that called for cutting the funding of the Centers for Disease Control and Prevention by almost half. Its chronic disease center was slated for elimination entirely, a proposal that came as a shock to many state and city health officials.
'Most Americans have some sort of ailment that could be considered chronic,' said Dr. Matifadza Hlatshwayo Davis, health director for the city of St. Louis.
Of the proposed cuts, she said, 'How do you reconcile that with trying to make America healthy again?'
The federal health department last month cut 2,400 jobs from the Centers for Disease Control and Prevention, whose National Center for Chronic Disease Prevention and Health Promotion runs on the largest budget within the agency.
Programs on lead poisoning, smoking cessation and reproductive health were jettisoned in a reorganization last month.
Overall, the proposed budget would cut the C.D.C.'s budget to about $4 billion, compared with $9.2 billion in 2024. The budget blueprint makes no mention of the Prevention and Public Health Fund, a $1.2 billion program.
If that figure is taken into account, the cut may be even larger than Mr. Trump's proposal indicates.
The agency would also lose a center focused on preventing injuries, including those caused by firearms, as well as programs for H.I.V. surveillance and prevention, and grants to help states prepare for public health emergencies.
According to the proposed budget, the cuts are needed to eliminate 'duplicative, D.E.I., or simply unnecessary programs.' Congress draws up the U.S. budget, but given the Republican majority and its fealty to Mr. Trump, it is unclear how much the proposal will change.
C.D.C. officials had been told that the functions of the chronic disease center would be moved to a new agency within the health department called the Administration for a Healthy America.
And the proposal released on Friday appears to allocate $500 million to the health secretary in part 'to tackle nutrition, physical activity, healthy lifestyles, overreliance on medication and treatments.'
But at the C.D.C., the chronic disease center's budget was nearly three times as large. And even if part of the chronic disease center is resuscitated in the A.H.A., it's unlikely that its new iteration would involve C.D.C. scientists relocated from Atlanta.
'The actual subject-matter experts, who administer the programs, might not be there at C.D.C. anymore,' said Dr. Scott Harris, state health officer at the Alabama Department of Public Health. 'We certainly don't have the same level of expertise in my state.'
The department of Health and Human Services did not respond to a request for comment.
The C.D.C.'s chronic disease center ran programs aimed at preventing cancer, heart disease, diabetes, epilepsy and Alzheimer's disease.
But the center has also seeded initiatives farther afield, ranging from creating rural and urban hiking trails to ensuring that healthy options like salads are offered in airports. It also promoted wellness programs in marginalized communities.
Dr. Davis, the health director in St. Louis, said her department was already reeling from cuts to programs to curb smoking and reduce lead poisoning and health disparities, as well as the rescinding of more than $11 billion that the C.D.C. had been providing to state health departments.
'I would take back Covid-19 in a heartbeat over what's happening right now,' Dr. Davis said.
In the proposed budget, the administration suggested that the eliminated programs would be better managed by states.
But state health departments already manage most chronic disease programs, and three-quarters of the C.D.C. center's funding goes to support them.
Loss of those funds 'would be devastating for us,' said Dr. Harris, the health officer in Alabama.
The state has one of the highest rates of chronic diseases in the country, and about 84 percent of the public health department's budget comes from the C.D.C., Dr. Harris said. About $6 million goes to chronic disease programs, including blood pressure screening, nutrition education for diabetes and promotion of physical activity.
If those funds are cut, 'I am at a loss right now to tell you where that would come from,' he added. 'It just seems that no one really knows what to expect, and we're not really being asked for any input on that.'
Minnesota's vaunted health department has already laid off 140 employees, and hundreds more may be affected if more C.D.C. funding is lost. Cuts to chronic disease prevention will affect nursing homes, vaccine clinics and public health initiatives for Native Americans in the state.
'The actions of the federal government have left us out on a flimsy limb with no safety net below us,' said Dr. Brooke Cunningham, the state's health commissioner.
Until recently, 'there seemed to be a shared understanding at the local, state and federal level that health was important to invest in,' Dr. Cunningham said.
The chronic disease center's work touches American lives in many unexpected ways.
In Prairie Village, Kan., Stephanie Barr learned about the center 15 years ago when, working as a waitress with no health insurance, she discovered a lump in her breast the size of a lemon.
Through the C.D.C.'s National Breast and Cervical Cancer Early Detection Program, she was able to get a mammogram and an ultrasound, and staff members helped her enroll in Medicaid for treatment after a biopsy determined the lump was malignant, Ms. Barr said.
'It was caught in the nick of time,' said Ms. Barr, now 45 and cancer free.
Since that program began in 1991, it has provided more than 16.3 million screening exams to more than 6.3 million people with no other affordable access, said Lisa Lacasse, president of the American Cancer Society Cancer Action Network.
The organization is one of 530 health associations that have signed a petition asking lawmakers to reject the proposed H.H.S. budget, which cuts the department's discretionary spending by about one-third. The signatories said the cuts would 'effectively devastate' the nation's research and public health infrastructure.
The budget also proposes dismantling disease registries and surveillance systems. 'If you don't collect the information or keep these surveillance systems going, you don't know what's happening, you don't know what the trends are,' said Dr. Philip Huang, director of Dallas County Health and Human Services.
'You're losing all of that history,' he said.
In a previous position as director of chronic diseases for Texas, Dr. Huang said he worked closely with C.D.C. experts who successfully reduced tobacco use among Americans. 'Eliminating the Office on Smoking and Health is just craziness if you're still wanting to address chronic diseases,' he said.
Smoking is still the leading cause of preventable death in the United States, causing more than 480,000 deaths each year, according to the C.D.C.
More than one in 10 American adults still smoke cigarettes regularly, but rates vary drastically by region, and C.D.C. surveillance helps target cessation programs to areas where they are needed most.
'Smoking rates have come down, but if the federal government takes its foot off the gas, the tobacco companies are ready to pop back up again,' said Erika Sward, assistant vice president for advocacy for the American Lung Association.
She warned that tobacco companies are constantly developing new products like nicotine pouches, whose use by teenagers doubled last year. 'It will take a lot more money to put the genie back in the bottle,' she said.
The C.D.C.'s chronic disease center works with communities and academic centers to promote effective programs, from creating quitting hotlines to reach young Iowans in rural areas to training members of Black churches in Columbia, S.C., to lead exercise and nutrition classes for their congregations.
In rural Missouri, dozens of walking trails have been developed in the 'boot heel' in the southeastern part of the state, an area with high rates of obesity and diabetes, said Ross Brownson, a public health researcher at Washington University in St. Louis who directs the Prevention Research Center in collaboration with the C.D.C.
'There's strong evidence now that if you change the walkability of a community, people will get more physical activity,' Dr. Brownson said. 'There aren't going to be health clubs in rural communities, but there is nature and the ability to have walking trails, and land is relatively cheap.'
With C.D.C. support, in Rochester, N.Y., people who are deaf and hard-of-hearing are being trained to lead exercise and wellness programs for other hearing-impaired people who can't easily participate in other gym classes.
In San Diego, researchers are testing ways to protect farm workers from exposure to ultraviolet rays and heat-related illnesses.
'Once they are up and started, they are community-driven and don't depend on the government,' said Allison Bay, who recently lost her job managing such projects at the C.D.C.
The C.D.C.'s reorganization also eliminated lead poisoning programs. Lead poisoning is also 'one of our greatest public health threats in the city of Cleveland,' said Dr. David Margolius, director of public health for the city.
The C.D.C. does not directly fund Cleveland's lead programs — the funding comes from the state. 'But just having the federal expertise to call on to help lead us toward a lead-free future, I mean, yeah, that has a big impact on us,' he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

Yahoo

time25 minutes ago

  • Yahoo

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

IQVIA Holdings experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade talks and overall strong corporate earnings have supported the upward trend, further enhancing IQV's market performance. We've identified 1 warning sign for IQVIA Holdings that you should be aware of. Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent 10% rise in IQVIA Holdings' share price has been influenced by important developments like the dosing in the RENEW Phase 2 trial and a key alliance with Sarah Cannon Research Institute. These initiatives are expected to potentially drive revenue growth, particularly as the strategic alliance optimizes oncology trials. The company's past performance, with total returns of 10.45% over five years, suggests modest growth in investor value. However, compared to the US Life Sciences industry's one-year return of 27% decline, IQVIA's recent rise highlights positive market sentiment. These initiatives, combined with FDA reforms and NVIDIA collaboration, may lower operational costs and have a favorable impact on earnings forecasts. Analysts predict revenue to grow by 5.2% annually over the next three years, which is somewhat cautious compared to the general expectations for the life sciences sector. The recent share price movement to US$146.2 remains below the consensus price target of US$216.31, indicating potential for future appreciation if the projected growth in revenue and earnings materializes. Click here to discover the nuances of IQVIA Holdings with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IQV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk

Yahoo

time40 minutes ago

  • Yahoo

RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk

Robert F. Kennedy Jr. testifying during his Senate Committee on Health, Education, Labor and Pensions confirmation hearing on January 30, 2025 in Washington, DC Credit - Kevin Dietsch—Getty Images When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. Read More: What to Know About RFK Jr. Removing All Experts From CDC Vaccine Advisory Committee During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Read More: What's the Risk of Getting Long COVID in 2024? Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans. Contact us at letters@

Slashing public health funding is a national security disaster in the making: Howard Dean
Slashing public health funding is a national security disaster in the making: Howard Dean

Yahoo

time40 minutes ago

  • Yahoo

Slashing public health funding is a national security disaster in the making: Howard Dean

Federal and state government officials are axing public health funding—and justifying the cuts with appeals to fiscal this slash-and-burn approach is enormously shortsighted. Every dollar 'saved' now will cost us far more—in both dollars and lives—when the next health emergency inevitably know the toll an infectious disease outbreak can take. We just lived through one. COVID-19 killed over 1 million Americans and cost our economy trillions. Government-funded initiatives—such as federally backed research into mRNA vaccines and 'field team' deployments to local outbreaks—saved us from an even worse those very systems are being torn apart. This year alone, over $1.8 billion in NIH research funding has been terminated. The CDC's Healthcare Infection Control Practices Advisory Committee, which sets safety standards for hospitals, was just eliminated. The new federal budget could cut funding for the Department of Health and Human Services by over a it's not just pandemic preparedness systems suffering from mass layoffs and budget cuts. Institutions designed to protect Americans from foodborne illnesses, antibiotic-resistant infections, and bioterrorism are being gutted as put, this is a catastrophic mistake—one that doesn't merely threaten our health and economy, but also our national officials have long warned that pandemics, bioterrorism, and emerging infections are critical threats to U.S. stability. The Defense Department reported to Congress earlier this year on how it continually works to monitor and prevent infectious disease outbreaks, given that 'a pandemic could potentially impact every component of the Department's ability to perform its mission.'The National Security Commission on Emerging Biotechnology also warned about the growing threat posed by biowarfare in a recent report. Because America's biotech industry is falling behind China's, in part due to the government's dwindling support for research, we're increasingly vulnerable to bioweapon attacks from adversaries, the report United States spends billions to prepare for military threats we hope never materialize. Our leaders need to fund disease prevention efforts with the same urgency we give to tanks and missiles. As we learned from COVID, infectious diseases can cause more death and destruction than even the most powerful conventional also showed us that pandemic preparedness pays dividends. Countries that invested more in limiting disease risks, such as Iceland and New Zealand, experienced lower mortality rates. By contrast, America suffered because we had allowed our public health infrastructure to erode for cannot afford to repeat—or worse, deepen—that mistake. Policymakers can prevent that from happening by restoring funding for public health agencies and investing in resources, such as labs, vaccines, and rapid response teams, that serve as our first and last lines of public health funding may be politically expedient, but preventing infectious disease isn't a partisan issue. Pathogens don't check party affiliation, respect national borders, or stop at state have a solemn duty—both to current citizens and to future generations of Americans—to strengthen the public health institutions that keep us safe. It's time for our leaders to act like Dean is the former chair of the Democratic National Committee and former governor of Vermont. The opinions expressed in commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune. This story was originally featured on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store